T cell senescence and contraction of T cell repertoire diversity in patients with chronic obstructive pulmonary disease

Clinical and Experimental Immunology

Volumn 155, Issue 3, 2009, Pages 466-475

  Lambers, C ^a   Hacker, S ^a   Posch, M ^a   Hoetzenecker, K ^a   Pollreisz, A ^a   Lichtenauer, M ^a   Klepetko, W ^a   Jan Ankersmit, H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

CD4+CD28null; COPD; Granzyme; Perforin; Smoking

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD94 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANZYME; GRANZYME B; NATURAL KILLER CELL RECEPTOR; PERFORIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4+ CD28 NULL T LYMPHOCYTE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER T CELL; NULL CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENESCENCE; SMOKE; T LYMPHOCYTE; UPREGULATION;

AGED; ANTIGENS, CD28; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELL AGING; CYTOKINES; FEMALE; FLOW CYTOMETRY; GRANZYMES; HUMANS; KILLER CELLS, NATURAL; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; PERFORIN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; ROC CURVE; SMOKING; T-LYMPHOCYTE SUBSETS;

EID: 59249087733     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03835.x     Document Type: Article

References (41)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease study. Lancet 1997 349 : 1269 76.
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997 349 : 1498 504.
3. Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 2000 117 : 1S 4S.
4. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002 121 : 121S 6S.
5. Lange P, Groth S, Nyboe GJ et al. Effects of smoking and changes in smoking habits on the decline of FEV1. Eur Respir J 1989 2 : 811 6.
6. Higenbottam T, Clark TJ, Shipley MJ, Rose G. Lung function and symptoms of cigarette smokers related to tar yield and number of cigarettes smoked. Lancet 1980 1 : 409 11.
7. Mercer PF, Shute JK, Bhowmik A, Donaldson GC, Wedzicha JA, Warner JA. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir Res 2005 6 : 151.
8. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003 107 : 1514 9.
9. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2007. Available at: http://www.goldcopd.org.
10. Hodge S, Hodge G, Nairn J, Holmes M, Reynolds PN. Increased airway granzyme b and perforin in current and ex-smoking COPD subjects. COPD 2006 3 : 179 87.
11. Hodge G, Nairn J, Holmes M, Reynolds PN, Hodge S. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects. Clin Exp Immunol 2007 150 : 22 9.
12. Di Stefano A, Caramori G, Capelli A et al. STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J 2004 24 : 78 85.
13. Di Stefano A, Capelli A, Lusuardi M et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Crit Care Med 1998 158 : 1277 85.
14. Campisi J. Replicative senescence: an old lives' tale? Cell 1996 84 : 497 500.
15. Goronzy JJ, Weyand CM. Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther 2003 5 : 225 34.
16. Choremi-Papadopoulou H, Viglis V, Gargalianos P, Kordossis T, Iniotaki-Theodoraki A, Kosmidis J. Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection. J Acquir Immune Defic Syndr 1994 7 : 245 53.
17. Hooper M, Kallas EG, Coffin D, Campbell D, Evans TG, Looney RJ. Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis. J Rheumatol 1999 26 : 1452 7.
18. Moosig F, Csernok E, Wang G, Gross WL. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin Exp Immunol 1998 114 : 113 8.
19. Markovic-Plese S, Cortese I, Wandinger KP, McFarland HF, Martin R. CD4+CD28- costimulation-independent T cells in multiple sclerosis. J Clin Invest 2001 108 : 1185 94.
20. Schirmer M, Goldberger C, Wurzner R et al. Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis. Arthritis Res 2002 4 : 71 6.
21. Griffiths GM, Alpert S, Lambert E, McGuire J, Weissman IL. Perforin and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis. Proc Natl Acad Sci USA 1992 89 : 549 53.
22. Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ. Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28- T cells from rheumatoid arthritis patients. J Immunol 1998 161 : 1018 25.
23. Lopez-Botet M, Bellon T. Natural killer cell activation and inhibition by receptors for MHC class I. Curr Opin Immunol 1999 11 : 301 7.
24. Lanier LL. NK cell receptors. Annu Rev Immunol 1998 16 : 359 93.
25. Global strategy for the diagnosis, management and prevention of chronic pulmonary disease (GOLD). NIH Publication no. 2701. National Heart, Lung, and Blood Institute/World Health Organization, 2005. Available at: http://www.goldcopd.org.
26. Rabe KF, Beghe B, Luppi F, Fabbri LM. Update in chronic obstructive pulmonary disease 2006. Am J Respir Crit Care Med 2007 175 : 1222 32.
27. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report of the Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993 16 : 5 40.
28. Shaffer JP. Modified sequentially rejective multiple test procedures. J Am Stat Assoc 1986 81 : 826 31.
29. Lanier LL. Back to the future - defining NK cells and T cells. Eur J Immunol 2007 37 : 1424 6.
30. Warrington KJ, Takemura S, Goronzy JJ, Weyand CM. CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum 2001 44 : 13 20.
31. Speiser DE, Valmori D, Rimoldi D et al. CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients. Eur J Immunol 1999 29 : 1990 9.
32. Gallin JI, Farber JM, Holland SM et al. Interferon-gamma in the management of infectious diseases. Ann Intern Med 1995 123 : 216 24.
33. Antoniou KM, Ferdoutsis E, Bouros D. Interferons and their application in the diseases in the lung. Chest 2003 123 : 209 16.
34. Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005 2 : 367 70 discussion 71 2.
35. Ionescu AA, Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003 46 : 64s 75s.
36. Calverley PM, Scott S. Is airway inflammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events? COPD 2006 3 : 233 42.
37. Friedman GD, Klatsky AL, Siegelaub AB. Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med 1976 294 : 1071 5.
38. Camilli AE, Robbins DR, Lebowitz MD. Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol 1991 133 : 795 800.
39. Nakajima T, Schulte S, Warrington KJ et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002 105 : 570 5.
40. Nakajima T, Goek O, Zhang X et al. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res 2003 93 : 106 13.
41. Pingiotti E, Cipriani P, Marrelli A et al. Surface expression of fractalkine receptor (CX3CR1) on CD4+/CD28 T cells in RA patients and correlation with atherosclerotic damage. Ann NY Acad Sci 2007 1107 : 32 41.